0.0015SEK-44.44%Mkt Cap: 908900 SEKP/E: —Last update: 2026-05-18
Lipigon Pharmaceuticals AB (publ), a clinical-stage pharmaceutical company, develops drugs for lipid related diseases in Sweden. Its product pipeline consists of Lipisense project, which is in phase II for the treatment …
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap908.90K SEK
Enterprise Value-9.31M SEK
Revenue (TTM)74.00K SEK
Gross Profit-22.84M SEK
Net Income (TTM)-32.44M SEK
Revenue/Share0.0000 SEK
Last Price0.0015 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0015382072
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA0.29
EV/Revenue-125.74
P/S12.28
P/B0.12
EPS (TTM)-0.08
EPS (Forward)—
52W Range
0.00110% of range0.1935
52W High0.1935 SEK
52W Low0.0011 SEK
Profitability
Gross Margin0.00%
Oper. Margin-10474.32%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-409.93%
ROA-276.40%
Growth
Revenue Growth-94.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-35.77M SEK
CapEx (TTM)108.00K SEK
FCF Margin-29871.96%
FCF Yield-2432.09%
Net Debt-10.21M SEK
Net Debt/EBITDA0.32
Balance Sheet
Debt/Equity—
Current Ratio3.00
Quick Ratio2.90
Book Value/Sh0.0130 SEK
Cash/Share0.0170 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.0100 SEK
Target Range0.0100 SEK – 0.0100 SEK
# Analysts1
Ownership
Shares Out.605.93M
Float583.54M
Insiders36.40%
Institutions7.89%
Technical
SMA 500.0047 (-68.0%)
SMA 2000.0627 (-97.6%)
Beta0.13
S&P 52W Chg27.23%
Avg Vol (30d)24.47M
Avg Vol (10d)32.60M
Technical Indicators
RSI (14)34.6
MACD-0.0008
MACD Signal-0.0008
MACD Hist.+0.0000
BB Upper0.0045 SEK
BB Middle0.0030 SEK
BB Lower0.0015 SEK
BB Width100.48%
ATR (14)0.0013 SEK
Vol Ratio (20d)5.68x